Unlocking PDAC initiation with AP-1
Nat Cancer
.
2021 Jan;2(1):14-15.
doi: 10.1038/s43018-020-00158-5.
Authors
Lindsay M LaFave
1
2
3
,
Jason D Buenrostro
4
5
Affiliations
1
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. lmlafave@mit.edu.
2
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. lmlafave@mit.edu.
3
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. lmlafave@mit.edu.
4
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. jason_buenrostro@harvard.edu.
5
Broad Institute of MIT and Harvard, Cambridge, MA, USA. jason_buenrostro@harvard.edu.
PMID:
35121892
DOI:
10.1038/s43018-020-00158-5
No abstract available
Publication types
Comment
MeSH terms
Carcinoma, Pancreatic Ductal* / therapy
Humans
Pancreatic Neoplasms* / diagnosis
Transcription Factor AP-1
Substances
Transcription Factor AP-1